Ixico set to report first-half loss as legacy issues unwind
10th May 2023 12:36
(Sharecast News) - Medical imaging analytics specialist Ixico reported first-half revenue of £3.2m in a trading update on Wednesday, down from £3.9m in the first six months of the 2022 financial year.
Read moreIxico wins £700,000 contract with biotech company
10th Mar 2023 08:43
(Sharecast News) - Clinical research firm Ixico has won a contract to provide MRI imaging services for patient selection and efficacy analysis in patients with a rare form of dementia.
Read moreIxico awarded two-year MRI imaging contract
9th Dec 2022 14:21
(Sharecast News) - Neuroscience analysis technology specialist Ixico has been selected by an unnamed, "leading" global pharmaceutical company and new client, it announced on Friday, to provide MRI imaging services for an early-phase clinical trial in multiple system atrophy.
Read moreFull-year revenue set to fall for Ixico
25th Oct 2022 14:27
(Sharecast News) - Artificial intelligence (AI) data analytics company Ixico flagged full-year revenue of £8.6m in a trading update on Tuesday, down from £9.2m year-on-year.
Read moreIxico to extend work on Huntington's disease trial
14th Jun 2022 15:38
(Sharecast News) - Neuroimaging-focussed contract research organisation Ixico announced on Tuesday that an existing client has asked it to extend its breadth of services on their phase 1 and 2 trial into Huntington's disease.
Read moreIxico joins Huntington's disease research consortium
10th May 2022 15:16
(Sharecast News) - Neuroimaging contract research provider Ixico has entered a multi-party consortium for the early detection of Huntington's disease (HD), it announced on Tuesday.
Read moreIxico confident after first-half revenues fall
25th Apr 2022 10:31
(Sharecast News) - Medical imaging technology company Ixico said in a trading update on Monday that it expected first-half revenues of £3.9m, down from £4.9m year-on-year.
Read moreIxico selected for Huntington's disease detection study
21st Apr 2022 13:50
(Sharecast News) - Artificial intelligence (AI) neuroimaging company Ixico announced on Thursday that it has been selected by a new client to support a global prospective observational study, assessing participants for the early detection of Huntington's disease (HD).
Read moreIxico wins £0.8m contract with existing US client
8th Mar 2022 15:31
(Sharecast News) - Medical analysis company Ixico has been selected by an existing United States biotechnology client, it announced on Tuesday, to provide PET and MRI neuroimaging services for an open-label phase 1 and 2 dose-finding study.
Read moreIxico wins contract from new European biopharmaceutical client
8th Feb 2022 15:17
(Sharecast News) - Medical imaging analytics company Ixico has been selected to provide PET and MRI imaging services to an unnamed "leading European biopharmaceutical company" specialising in neurodegenerative conditions, it announced on Tuesday.
Read moreIxico extends commitment to Dementias Platform UK
26th Jan 2022 16:02
(Sharecast News) - Data analytics company Ixico has extended its commitment to Dementias Platform UK (DPUK), it announced on Wednesday, as it entered its second phase.
Read moreIxico tapped for another phase-3 clinical trial
1st Nov 2021 15:43
(Sharecast News) - Artificial intelligence (AI) data analytics company Ixico has been selected by its largest pharmaceutical client to provide neuroimaging services for a new phase 3 clinical trial focussed on a demyelinating disorder, it announced on Monday.
Read moreIxico FY revenues projected to beat expectations
18th Oct 2021 09:33
(Sharecast News) - AI data analytics company Ixico said on Monday that full-year revenues were projected to have beat expectations despite falling shy of prior year comparatives.
Read moreIxico secures new contract valued at more than $750,000
22nd Sep 2021 11:19
(Sharecast News) - AI data analytics firm Ixico has secured a new contract valued at more than $750,000 over two years for advanced neuroimaging solutions.
Read moreIxico awarded phase 1 clinical trial contract
8th Sep 2021 12:47
(Sharecast News) - Neuroscience artificial intelligence (AI) company Ixico has been awarded a contract by a new biopharmaceutical client to support its phase 1 multiple system atrophy clinical trial, it announced on Wednesday.
Read more